Takeda Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 4, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Cap	56,129	7,353,334	6,848,480	8,050,471	7,120,067	8,970,663
Market Cap Growth	30.75%	7.37%	-14.93%	13.07%	-20.63%	20.72%
Enterprise Value	86,339	7,353,334	693,719,373	609,697,468	552,475,030	580,372,580
Last Close Price	18.16	14.87	13.89	16.48	14.32	18.26
PE Ratio	40.36	66.32	46.15	21.67	23.91	16.93
Forward PE	34.27	-	-	-	-	-
PS Ratio	1.97	0.01	0.01	0.01	0.01	0.02
PB Ratio	1.15	-	0.01	0.01	0.01	0.01
P/TBV Ratio	-	-	-	0.01	0.01	0.01
P/FCF Ratio	8.74	0.05	0.08	0.06	0.05	0.06
P/OCF Ratio	7.40	0.04	0.06	0.05	0.04	0.06
EV/Sales Ratio	3.03	0.01	1.04	0.96	0.99	1.16
EV/EBITDA Ratio	10.63	0.04	4.14	3.18	3.20	3.38
EV/EBIT Ratio	22.44	0.14	23.49	7.92	7.63	7.25
EV/FCF Ratio	13.44	0.05	8.16	4.64	3.52	4.11
Debt / Equity Ratio	0.63	-	0.67	0.69	0.76	0.90
Debt / EBITDA Ratio	8.00	-	4.54	3.60	3.96	4.24
Debt / FCF Ratio	-	-	8.96	5.24	4.35	5.15
Net Debt / Equity Ratio	0.54	-	0.60	0.60	0.61	0.70
Net Debt / EBITDA Ratio	6.74	-	4.10	3.14	3.16	3.32
Net Debt / FCF Ratio	-	-	8.08	4.58	3.47	4.04
Asset Turnover	0.30	0.61	0.29	0.30	0.27	0.25
Inventory Turnover	1.17	2.61	1.30	1.35	1.38	1.31
Quick Ratio	0.58	-	0.48	0.50	0.75	1.02
Current Ratio	1.19	-	1.06	0.97	1.21	1.53
Return on Equity (ROE)	4.52%	2.97%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	4.77%	6.27%	-3.12%	4.16%	4.38%	3.85%
Return on Invested Capital (ROIC)	5.36%	6.98%	-3.51%	4.79%	5.09%	4.40%
Return on Capital Employed (ROCE)	4.70%	5.40%	1.56%	4.35%	4.16%	4.68%
Earnings Yield	1.28%	1.51%	2.17%	4.61%	4.18%	5.91%
FCF Yield	11.45%	1829.87%	1241.02%	1632.60%	2206.42%	1575.87%
Dividend Yield	2.91%	0.00%	0.00%	4.11%	5.20%	4.48%
Payout Ratio	117.40%	280.54%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-	110.81%	5.34%	52.56%	171.09%	3.75%
Total Shareholder Return	-	110.81%	5.34%	56.67%	176.29%	8.23%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q